Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096382
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2004-11-09
Brief Title:
Cyclophosphamide Fludarabine and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy Autologous Stem Cell Transplantation and Interleukin-2 in Treating Patients With Metastatic Melanoma
Sponsor:
National Institutes of Health Clinical Center CC
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
040288
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institutes of Health Clinical Center CC
Lead Sponsor Class:
NIH
Responsible Party:
Steven Rosenberg MD
Responsible Party Title:
Principal investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Institutes of Health Clinical Center CC
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |